Article

Acucela receives 'Emerging Leader' award

Acucela Inc. has been named as a recipient of the 2012 Emerging Leaders award from the Japan-U.S. Innovation Awards

Seattle-Acucela Inc. has been named as a recipient of the 2012 Emerging Leaders award from the Japan-U.S. Innovation Awards.

Acucela is a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases.

Now in its second year, the Japan-U.S. Innovation Awards program is sponsored by the Japan Society of Northern California in collaboration with the Stanford University U.S.-Asia Technology Management Center. The awards are designed to recognize the synergy between Japan and the United States by honoring outstanding companies from both countries that have achieved highly noteworthy innovation in their business or technology.

The Emerging Leaders award highlights two companies-one from Japan and one from the United States-that are young, small, dynamic, growing, entrepreneurial, and have a credible footprint in both Japan and the United States.

“It is an honor to accept this award on behalf of Acucela, and a testament to the important work our entire team contributes every day to continue the fight against blinding eye diseases,” said Ryo Kubota, MD, PhD, Acucela’s chairman, president, and chief executive officer.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.